Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
Abstract Although hormone therapy is effective for the treatment of prostate cancer (Pca), many patients develop a lethal type of Pca called castration-resistant prostate cancer (CRPC). Dysregulation of DNA damage response (DDR)-related genes leads to Pca progression. Here, we explored DDR-related s...
Main Authors: | Masashi Oshima, Ken-ichi Takayama, Yuta Yamada, Naoki Kimura, Haruki Kume, Tetsuya Fujimura, Satoshi Inoue |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-46651-6 |
Similar Items
-
Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer
by: Taketo Kawai, et al.
Published: (2023-12-01) -
Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer
by: Yuji Hakozaki, et al.
Published: (2022-09-01) -
Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
by: Tetsuya Fujimura, et al.
Published: (2018-01-01) -
The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy.
by: Yuta Takeshima, et al.
Published: (2022-01-01) -
The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy
by: Yuta Takeshima, et al.
Published: (2022-01-01)